Oragenics Inc (OGEN) concluded trading on Wednesday at a closing price of $0.32, with 11.24 million shares of worth about $3.6 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -77.59% during that period and on December 18, 2024 the price saw a loss of about -2.99%. Currently the company’s common shares owned by public are about 12.21M shares, out of which, 9.67M shares are available for trading.
Stock saw a price change of -8.66% in past 5 days and over the past one month there was a price change of 12.07%. Year-to-date (YTD), OGEN shares are showing a performance of -94.22% which decreased to -93.91% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.25 but also hit the highest price of $7.74 during that period. The average intraday trading volume for Oragenics Inc shares is 452.08K. The stock is currently trading 0.34% above its 20-day simple moving average (SMA20), while that difference is down -0.70% for SMA50 and it goes to -67.23% lower than SMA200.
Oragenics Inc (AMEX: OGEN) currently have 12.21M outstanding shares and institutions hold larger chunk of about 1.35% of that.
The stock has a current market capitalization of $3.97M and its 3Y-monthly beta is at 0.44. It has posted earnings per share of -$5.73 in the same period. It has Quick Ratio of 1.93 while making debt-to-equity ratio of 0.17. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OGEN, volatility over the week remained 9.38% while standing at 10.29% over the month.
